Pelus Louis M, Broxmeyer Hal E
Department of Microbiology & Immunology, Indiana University School of Medicine, 950 W Walnut Street, R2-301, Indianapolis, IN 46202.
Curr Stem Cell Rep. 2018 Dec;4(4):273-281. doi: 10.1007/s40778-018-0141-9. Epub 2018 Oct 23.
Mobilized peripheral blood is the predominant source of stem and progenitor cells for hematologic transplantation. Successful transplant requires sufficient stem cells of high enough quality to recapitulate lifelong hematopoiesis, but in some patients and normal donors, reaching critical threshold stem cell numbers are difficult to achieve. Novel strategies, particularly those offering rapid mobilization and reduced costs, remains an area of interest.This review summarizes critical scientific underpinnings in understanding the process of stem cell mobilization, with a focus on new or improved strategies for their efficient collection and engraftment.
Studies are described that provide new insights into the complexity of stem cell mobilization. Agents that target new pathways such HSC egress, identify strategies to collect more potent competing HSC and new methods to optimize stem cell collection and engraftment are being evaluated.
Agents and more effective strategies that directly address the current shortcomings of hematopoietic stem cell mobilization and transplantation and offer the potential to facilitate collection and expand use of mobilized stem cells have been identified.
动员外周血是血液学移植中干细胞和祖细胞的主要来源。成功的移植需要足够数量且质量足够高的干细胞来重建终身造血功能,但在一些患者和正常供体中,达到临界阈值的干细胞数量很难实现。新的策略,尤其是那些能够实现快速动员并降低成本的策略,仍然是一个备受关注的领域。本综述总结了理解干细胞动员过程的关键科学基础,重点关注其有效采集和植入的新策略或改进策略。
所描述的研究为干细胞动员的复杂性提供了新的见解。正在评估针对新途径(如造血干细胞流出)的药物、收集更具潜力的竞争性造血干细胞的策略以及优化干细胞采集和植入的新方法。
已经确定了直接解决造血干细胞动员和移植当前缺点并有可能促进动员干细胞采集和扩大其使用的药物和更有效的策略。